MedPath

Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging

Not Applicable
Completed
Conditions
Infertility
Registration Number
NCT01939626
Lead Sponsor
Vitrolife
Brief Summary

The purpose of this study is to compare human embryo in vitro development in sequential and single-step culture medium using time-lapse imaging.

Detailed Description

Objective: To study whether a culture medium that allows undisturbed culture supports human embryo development to the blastocyst stage equivalently to a well-established sequential media.

Design: Randomized, double-blinded sibling trial. Setting: Independent in vitro fertilization (IVF) clinics. Patient(s): One hundred twenty-eight patients, with 1,356 zygotes randomized into two study arms.

Intervention(s): Embryos from each patient were randomly allocated into two study arms to compare embryo development on a time-lapse system using a single-step medium or sequential media.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
128
Inclusion Criteria
  • 6 or more normal embryos following egg retrieval and fertilization.
  • Female patients aged 21-40 years or 21-55 years who are using an egg donor.
  • Patients using fresh or frozen ejaculated sperm
Exclusion Criteria
  • Previous history of cancer
  • Day 3 embryo transfer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of good quality blastocysts5 days of in vitro embryo culture

A cohort of human embryos will be divided into two different media. The ability of the media to support human embryo development will be determined using the standard assessment of the percentage of embryos that achieve a defined embryo grade.

Secondary Outcome Measures
NameTimeMethod
% GQE DAY 3Measured 3 days after oocyte pick-up

Percentage of good quality embryos on day 3 of development

Blast. rateMeasured 5 and 6 days after oocyte pick-up.

Number of embryos reaching the blastocyts stage on either day 5 or day 6.

Blast. Utilization rateMeasured 5 and 6 days after oocyte pick-up

Number of blastocyst that are cryopreserved or transfered on either day 5 or 6 of embryo development.

Trial Locations

Locations (4)

Pacific Fertility Center

🇺🇸

San Francisco, California, United States

Frisco IVF

🇺🇸

Frisco, Texas, United States

Fertilitetscentrum

🇸🇪

Goteburg, Sweden

Skanes University Hospital

🇸🇪

Malmo, Sweden

Pacific Fertility Center
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.